ADUS - Addus HomeCare Corporation
NASDAQ
->
Healthcare
->
Medical Care Facilities
Frisco,
United States
Type: Equity
ADUS price evolution
ADUS
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $222.85 | $173.31 | $76.72 | $64.79 |
| Short term investments | ||||
| Net receivables | $96.6 | $109.19 | $104.73 | $115.5 |
| Inventory | ||||
| Total current assets | $332.81 | $294.99 | $191.85 | $200 |
| Long term investments | ||||
| Property, plant & equipment | $68.25 | $67.53 | $68.57 | $69.44 |
| Goodwill & intangible assets | $752.25 | $753.58 | $754.98 | |
| Total noncurrent assets | $821.57 | $822.15 | $824.42 | |
| Total investments | ||||
| Total assets | $1152.9 | $1116.55 | $1014 | $1024.43 |
| Current liabilities | ||||
| Accounts payable | $27.73 | $20.19 | $22.02 | $26.18 |
| Deferred revenue | ||||
| Short long term debt | $11.22 | $11.31 | $11.34 | |
| Total current liabilities | $157.82 | $147.53 | $141.59 | $145.12 |
| Long term debt | $38.36 | $138.39 | $163.84 | |
| Total noncurrent liabilities | $47.37 | $147.27 | $172.62 | |
| Total debt | $49.58 | $149.7 | $175.18 | |
| Total liabilities | $205.27 | $194.9 | $288.86 | $317.73 |
| Shareholders' equity | ||||
| Retained earnings | $356.9 | $336.74 | $318.66 | $302.83 |
| Other shareholder equity | $947.63 | $921.65 | $706.69 | |
| Total shareholder equity | $921.65 | $725.14 | $706.69 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $64.79 | $79.96 | $168.9 | $145.08 |
| Short term investments | ||||
| Net receivables | $115.5 | $126.17 | $136.96 | $132.65 |
| Inventory | ||||
| Total current assets | $200 | $222.81 | $324.34 | $287.7 |
| Long term investments | ||||
| Property, plant & equipment | $69.44 | $60.16 | $54.53 | $57.74 |
| Goodwill & intangible assets | $754.98 | $655.02 | $568.71 | $540.62 |
| Total noncurrent assets | $824.42 | $715.19 | $623.24 | $604.88 |
| Total investments | ||||
| Total assets | $1024.43 | $937.99 | $947.59 | $892.58 |
| Current liabilities | ||||
| Accounts payable | $26.18 | $22.09 | $19.36 | $23.7 |
| Deferred revenue | ||||
| Short long term debt | $11.34 | $0.97 | ||
| Total current liabilities | $145.12 | $131.15 | $117.69 | $143.9 |
| Long term debt | $163.84 | $131.77 | $253.77 | $229.42 |
| Total noncurrent liabilities | $172.62 | $173.31 | $255.55 | $230 |
| Total debt | $175.18 | $167.25 | $253.77 | $230.39 |
| Total liabilities | $317.73 | $304.45 | $373.24 | $373.91 |
| Shareholders' equity | ||||
| Retained earnings | $302.83 | $240.32 | $194.29 | $149.16 |
| Other shareholder equity | ||||
| Total shareholder equity | $706.69 | $633.54 | $574.34 | $518.68 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $289.79 | $286.92 | $280.75 | $276.35 |
| Cost of revenue | $193.76 | $192.57 | $183.94 | |
| Gross Profit | $92.2 | $93.16 | $88.18 | $92.41 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $63.58 | $61.06 | $60.77 | |
| Total operating expenses | $66.25 | $66.98 | $64.53 | $64.44 |
| Operating income | $26.18 | $23.64 | $27.97 | |
| Income from continuing operations | ||||
| EBIT | $26.66 | $24.07 | $28.47 | |
| Income tax expense | $7.13 | $6.46 | $5.48 | $5.78 |
| Interest expense | $1.33 | $2.11 | $2.76 | $3.12 |
| Net income | ||||
| Net income | $20.16 | $18.08 | $15.83 | $19.58 |
| Income (for common shares) | $18.08 | $15.83 | $19.58 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1058.65 | $951.12 | $864.5 | $764.77 |
| Cost of revenue | $718.77 | $651.38 | $594.65 | $538.54 |
| Gross Profit | $339.88 | $299.74 | $269.85 | $226.24 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $234.79 | $216.94 | $189.42 | $169.68 |
| Total operating expenses | $248.92 | $231 | $203.91 | $181.73 |
| Operating income | $90.96 | $68.74 | $65.94 | $44.51 |
| Income from continuing operations | ||||
| EBIT | $92.43 | $69.08 | $66.2 | $45.13 |
| Income tax expense | $18.81 | $14.15 | $15.27 | $8.81 |
| Interest expense | $11.11 | $8.91 | $5.81 | $3.19 |
| Net income | ||||
| Net income | $62.52 | $46.02 | $45.13 | $33.13 |
| Income (for common shares) | $62.52 | $46.02 | $45.13 | $33.13 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $18.08 | $15.83 | $19.58 | |
| Operating activities | ||||
| Depreciation | $3.4 | $3.47 | $3.68 | |
| Business acquisitions & disposals | $4.6 | -$0.4 | $0 | |
| Stock-based compensation | $2.85 | $2.62 | $2.49 | |
| Total cash flows from operations | $18.81 | $38.68 | $30.05 | |
| Investing activities | ||||
| Capital expenditures | -$1.05 | -$1.35 | -$5.3 | |
| Investments | ||||
| Total cash flows from investing | -$0.12 | $3.55 | -$1.75 | -$5.3 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $175.58 | $0.29 | ||
| Net borrowings | -$101.35 | -$25 | -$40 | |
| Total cash flows from financing | $52.17 | $74.22 | -$25 | -$39.71 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $158.06 | $96.59 | $11.93 | -$14.96 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $62.52 | $46.02 | $45.13 | $33.13 |
| Operating activities | ||||
| Depreciation | $14.13 | $14.06 | $14.49 | $12.05 |
| Business acquisitions & disposals | -$109.8 | -$98.29 | -$37.37 | -$207.41 |
| Stock-based compensation | $10.32 | $10.63 | $9.43 | $6 |
| Total cash flows from operations | $112.25 | $105.11 | $39.49 | $109.41 |
| Investing activities | ||||
| Capital expenditures | -$9.44 | -$8.3 | -$4.64 | -$6.83 |
| Investments | ||||
| Total cash flows from investing | -$119.24 | -$106.59 | -$42.02 | -$214.24 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.32 | $2.55 | $1.11 | $3.95 |
| Net borrowings | -$8.5 | -$90 | $25.24 | $134.24 |
| Total cash flows from financing | -$8.18 | -$87.45 | $26.34 | $138.19 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$15.17 | -$88.93 | $23.82 | $33.36 |
News
Fundamentals
| Market cap | $2.27B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 18.10M |
| Revenue | $1.13B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $73.65M |
| Revenue Q/Q | 7.04% |
| Revenue Y/Y | 10.15% |
| P/E ratio | 30.80 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.00 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 12.31 |
| EPS | $4.07 |
|---|---|
| ROA | 6.84% |
| ROE | N/A |
| Debt/Equity | 0.45 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.11 |
| Quick ratio | N/A |